首页OCEAW • NASDAQ
add
Ocean Biomedical
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | — | — |
经营支出 | 76.80万 | -71.07% |
净收入 | -552.80万 | 60.76% |
净利润率 | — | — |
每股收益 | — | — |
息税折旧摊销前利润 | — | — |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | — | — |
总资产 | 113.20万 | 9.80% |
负债总额 | 9921.70万 | 30.11% |
权益总额 | -9808.50万 | — |
发行在外的股份 | 3486.86万 | — |
市净率 | -0.01 | — |
资产回报率 | -128.73% | — |
资本回报率 | 2.46% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -552.80万 | 60.76% |
来自运营的现金 | -88.50万 | 21.68% |
投资现金 | — | — |
融资现金 | 89.60万 | — |
现金净变动 | 1.10万 | 100.97% |
自由现金流 | 161.79万 | 294.11% |
简介
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
成立时间
2019
员工数量
7
